Functional MR imaging evidence of altered functional activation in metabolic syndrome

American Journal of Neuroradiology

Volumn 32, Issue 3, 2011, Pages 541-547

  Hoth, K F ^a,b   Gonzales, M M ^c   Tarumi, T ^c   Miles, S C ^c   Tanaka, H ^c   Haley, Andreana P ^c  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INFERIOR PARIETAL LOBULE; MALE; METABOLIC SYNDROME X; SUPERIOR FRONTAL GYRUS; SUPERIOR PARIETAL LOBULE; VERBAL MEMORY; WORKING MEMORY;

ADULT; BRAIN; EVOKED POTENTIALS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 79952796147     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2315     Document Type: Article

References (56)

1. The Silver Book: Chronic Disease and Medical Innovation in an Aging Nation. http://www.silverbook.org. Accessed 2007
2. Gaugler JE, Yu F, Krichbaum K, et al. Predictors of nursing home admission for persons with dementia. Med Care 2009;47:191-98
3. Athilingam P, King KB. Heart and brain matters in heart failure: a literature review. J N Y State Nurses Assoc 2007;38:13-19
4. Erkinjuntti T, Roman G, Gauthier S, et al. Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke 2004;35:1010-17 (Pubitemid 38419819)
5. Erkinjuntti T. Diagnosis and management of vascular cognitive impairment and dementia. J Neural Transm Suppl 2002;91-109 (Pubitemid 38471311)
6. Farlow MR. Use of antidementia agents in vascular dementia: beyond Alzheimer disease. Mayo Clin Proc 2006;81:1350-58 (Pubitemid 44484974)
7. Nyenhuis DL, Gorelick PB. Diagnosis and management of vascular cognitive impairment. Curr Atheroscler Rep 2007;9:326-32 (Pubitemid 350081477)
8. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-45. Epub 2009 Oct 5
9. Akbaraly TN, Kivimaki M, Shipley MJ, et al. Metabolic syndrome over 10 years and cognitive functioning in late midlife: the Whitehall II study. Diabetes Care 2010;33:84-89. Epub 2009 Oct 16
10. Kalmijn S, Foley D, White L, et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men: the Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 2000;20:2255-60
11. Yaffe K, Haan M, Blackwell T, et al. Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 2007;55:758-62 (Pubitemid 46668964)
12. Yaffe K, Weston AL, Blackwell T, et al. The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol 2009;66:324-28
13. Gatto NM, Henderson VW, St John JA, et al. Metabolic syndrome and cognitive function in healthy middle-aged and older adults without diabetes. Neuropsychol Dev Cog B Neuropsychol Cog 2008;15:627-41. Epub 2008 May 16
14. Dik MG, Jonker C, Comijs HC, et al. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 2007;30:2655-60 (Pubitemid 47547816)
15. Vanhanen M, Koivisto K, Moilanen L, et al. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 2006;67:843-47 (Pubitemid 44394200)
16. Raffaitin C, Gin H, Empana J-P, et al. Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study. Diabetes Care 2009;32:169-74
17. Segura B, Jurado MA, Freixenet N, et al. Mental slowness and executive dysfunctions in patients with metabolic syndrome. Neurosci Lett 2009;462:49-53
18. Yaffe K. Metabolic syndrome and cognitive disorders: is the sum greater than its parts? Alzheimer Dis Assoc Disord 2007;21:167-71 (Pubitemid 46878980)
19. Bokura H, Yamaguchi S, Iijima K, et al. Metabolic syndrome is associated with silent ischemic brain lesions. Stroke 2008;39:1607-09
20. Segura B, Jurado MA, Freixenet N, et al. Microstructural white matter changes in metabolic syndrome: a diffusion tensor imaging study. Neurology 2009;73:438-44
21. Park K, Yasuda N, Toyonaga S, et al. Significant associations of metabolic syndrome and its components with silent lacunar infarction in middle aged subjects. J Neurol Neurosurg Psychiatry 2008;79:719-21 (Pubitemid 351829449)
22. Sweet LH, Rao SM, Primeau M, et al. Functional magnetic resonance imaging of working memory among multiple sclerosis patients. J Neuroimaging 2004;14:150-57 (Pubitemid 38391824)
23. Machulda MM, Ward HA, Borowski B, et al. Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology 2003;61:500-06 (Pubitemid 37025367)
24. Saykin AJ, Flashman LA, Frutiger SA, et al. Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: patterns of functional MRI activation. J Int Neuropsychol Soc 1999;5:377-92 (Pubitemid 29385187)
25. Chang L, Speck O, Miller EN, et al. Neural correlates of attention and working memory deficits in HIV patients. Neurology 2001;57:1001-07 (Pubitemid 32880193)
26. Bondi MW, Houston WS, Eyler LT, et al. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 2005;64:501-08 (Pubitemid 40189870)
27. Filbey FM, Slack KJ, Sunderland TP, et al. Functional magnetic resonance imaging and magnetoencephalography differences associated with APOE ε4 in young healthy adults. Neuroreport 2006;17:1585-90 (Pubitemid 44454761)
28. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971;9:97-113
29. Wechsler D. Wechsler Abbreviated Scale of Intelligence Manual. San Antonio, Texas: Harcourt Assessment Company; 1999
30. Lezak MD. Neuropsychological Assessment. New York: Oxford University Press; 1995
31. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98
32. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-65 (Pubitemid 19239715)
33. Delis DC, Kramer JH, Kaplan E, et al. California Verbal Learning Test (CVLT-II) Manual. San Antonio, Texas: Harcourt Assessment Company; 2000
34. Lewis RF. Digit Vigilance Test. Odessa, California: Psychological Assessment Resources; 1995
35. Eslinger P. The Iowa Screening Battery for Mental Decline. Iowa City, Iowa: University of Iowa College of Medicine; 1984
36. Reitan R. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8: 271-76
37. Klove H, Forster FM. Clinical neuropsychology. In: The Medical Clinics of North America. New York: Saunders; 1963
38. Beck AT, Steer RA, Brown GK. BDI-II Manual. Fort Worth, Texas: The Psychological Corporation; 1996
39. Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996;29:162-73 (Pubitemid 26266657)
40. Haley AP, Sweet LH, Gunstad J, et al. Verbal working memory and atherosclerosis in patients with cardiovascular disease: an fMRI study. J Neuroimaging 2007;17:227-33 (Pubitemid 47022940)
41. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain 3-D Proportional System: An Approach to Cerebral Imaging. New York: Thieme Medical Publishers; 1988
42. Ravizza SM, Delgado MR, Chein JM, et al. Functional dissociations within the inferior parietal cortex in verbal working memory. Neuroimage 2004;22:562-73 (Pubitemid 38759418)
43. Haley AP, Forman DE, Poppas A, et al. Carotid artery intima-media thickness and cognition in cardiovascular disease. Int J Cardiol 2007;121:148-54 (Pubitemid 47385831)
44. Cohen RA, Poppas A, Forman DE, et al. Vascular and cognitive functions associated with cardiovascular disease in the elderly. J Clin Exp Neuropsychol 2009;31:96-110
45. Forman DE, Cohen RA, Hoth KF, et al. Cognition and brachial endothelial responses in older adults with cardiovascular disease. Artery Research 2008;2:35-43. Epub 2008 Jun 16
46. Brookheimer SY, Stojwas MH, Cohen MS, et al. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 2000;343:450-56 (Pubitemid 30646483)
47. Sweet LH, Rao SM, Primeau M, et al. Functional magnetic resonance imaging response to increased verbal working memory demands among patients with multiple sclerosis. Hum Brain Mapp 2006;27:28-36 (Pubitemid 43202732)
48. Gonzales MM, Tarumi T, Tanaka H, et al. Functional imaging of working memory and peripheral endothelial function in middle-aged adults. Brain Cogn 2010;73:146-51
49. Haley AP, Gunstad J, Cohen RA, et al. Neural correlates of visuospatial working memory in healthy young adults at risk for hypertension. Brain Imaging Behav 2008;2:192-99
50. Irani F, Sweet L, Haley A, et al. An fMRI study of verbal working memory, cardiac output, and ejection fraction in elderly patients with cardiovascular disease. Brain Imaging Behav 2009;3:350-57
51. Gunstad J, Cohen RA, Tate DF, et al. Blood pressure variability and white matter hyperintensities in older adults with cardiovascular disease. Blood Press 2005;14:353-58 (Pubitemid 43135733)
52. Hoth KF, Tate DF, Poppas A, et al. Endothelial function and white matter hyperintensities in older adults with cardiovascular disease. Stroke 2007;38:308-12. Epub 2007 Jan 4 (Pubitemid 46184300)
53. Jefferson AL, Tate DF, Poppas A, et al. Lower cardiac output is associated with greater white matter hyperintensities in older adults with cardiovascular disease. J Am Geriatr Soc 2007;55:1044-48 (Pubitemid 47024621)
54. Jefferson AL, Poppas A, Paul RH, et al. Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients. Neurobiol Aging 2007;28:477-83 (Pubitemid 46178529)
55. Paul RH, Gunstad J, Poppas A, et al. Neuroimaging and cardiac correlates of cognitive function among patients with cardiac disease. Cerebrovasc Dis 2005;20:129-33 (Pubitemid 41160213)
56. Sachdev P, Chen X, Wen W. White matter hyperintensities in mid-adult life. Curr Opin Psychiatry 2008;21:268-74 (Pubitemid 351489347)